Yasunori Emi
Tenjin, 8100001, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Phase II study of long-course chemoradiotherapy followed by consolidation chemotherapy as total neoadjuvant therapy in locally advanced rectal cancer in Japan: ENSEMBLE-2.
Journal: Annals of gastroenterological surgery
Published: May 23, 2024
A 30-Month Survival Case of Undifferentiated Carcinoma of the Duodenum Treated by Pancreaticoduodenectomy
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: October 06, 2023
Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial.
Journal: Cancers
Published: July 07, 2022
A case of successful conversion surgery for locally advanced pancreatic cancer with synchronous triple cancer of the lung and esophagus: a case report.
Journal: Surgical case reports
Published: November 04, 2021
Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases.
Journal: International journal of clinical oncology
Published: April 21, 2021
Safety and efficacy of S-1 plus oxaliplatin 130 mg/m2 combination therapy in patients with previously untreated HER2-negative unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: a phase II trial (KSCC1501A).
Journal: International journal of clinical oncology
Published: June 12, 2020
RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma: A Large-cohort Observational Study (KSCC1307).
Journal: Annals of surgery
Published: June 03, 2020
Retrospective Examination of Usefulness and Adverse Effects of Tapentadol in Patients with Cancer Pain during Anticancer Treatment
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 22, 2019
Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival.
Journal: International journal of clinical oncology
Published: August 13, 2019
Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.
Journal: Cancer chemotherapy and pharmacology
Published: July 21, 2019
Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial).
Journal: British journal of cancer
Published: March 16, 2019
Last Updated: 09/26/2026